The efficacy and safety of fecal microbiota transplantation in the treatment of sarcopenia: a retrospective study
These results underscore the promise of microbial-based therapies, including fecal microbiota transplantation (FMT), as groundbreaking strategies for addressing sarcopenia. The research indicates that integrating FMT with resistance training could improve muscle mass and function while alleviating inflammation in sarcopenia patients, presenting a hopeful avenue for effective management of the condition.
Authors
- Di Zhao (ORCID: https://orcid.org/0000-0001-7045-0080)
- Bo Yang (ORCID: https://orcid.org/0000-0002-1347-3718)
- Zhongchen Liu (ORCID: https://orcid.org/0000-0002-3541-2211)
- Le Wang (ORCID: https://orcid.org/0009-0000-8080-0849)
- Ning Li (ORCID: https://orcid.org/0000-0003-3880-5464)
- Jiahui Wang (ORCID: https://orcid.org/0000-0002-0867-8612)
- Long Huang
- Xinhui Li (ORCID: https://orcid.org/0000-0003-1568-1999)
- Zhifeng Wu (ORCID: https://orcid.org/0000-0003-3870-8314)
- Yue Xu
- Qiyi Chen (ORCID: https://orcid.org/0000-0003-4960-3868)
Institutions
- Tongji University (CN)
- Huazhong Agricultural University (CN)
- Soochow University (CN)
- Zhangjiagang First People's Hospital (CN)
- Liaoning Cancer Hospital & Institute (CN)
- China Medical University (CN)
Publication Details
- Journal
- Journal of Translational Medicine
- Published
- 2025-06-11
- DOI
- https://doi.org/10.1186/s12967-025-06557-5
- Citations
- 5
- Primary Topic
- Nutrition and Health in Aging
- Type
- article
- Field-Weighted Citation Impact
- 5.82
Funders
- National Natural Science Foundation of China
- National Key Research and Development Program of China